<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39130813</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2050-0904</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical case reports</Title><ISOAbbreviation>Clin Case Rep</ISOAbbreviation></Journal><ArticleTitle>New-onset sarcoidosis in a patient with long COVID.</ArticleTitle><Pagination><StartPage>e9186</StartPage><MedlinePgn>e9186</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e9186</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccr3.9186</ELocationID><Abstract><AbstractText>Long COVID, often following SARS-CoV-2 infection, may stem from sustained inflammation, overlapping with autoimmune diseases like sarcoidosis. Though specific treatments lack, this link could shape future diagnostic and therapeutic methods.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Clinical Case Reports published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodriguez-Nava</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9826-7050</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Kamari</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Harvey</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology Memorial Medical Center Modesto California USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egoryan</LastName><ForeName>Goar</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5203-8156</Identifier><AffiliationInfo><Affiliation>Division of Oncology, Department of Medicine Stanford University School of Medicine Stanford California USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla</LastName><ForeName>Hector F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Post-Acute COVID-19 Syndrome Clinic Stanford Health Care Stanford California USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Clinic Stanford Health Care Stanford California USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Case Rep</MedlineTA><NlmUniqueID>101620385</NlmUniqueID><ISSNLinking>2050-0904</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">sarcoidosis</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>12</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>12</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39130813</ArticleId><ArticleId IdType="pmc">PMC11316136</ArticleId><ArticleId IdType="doi">10.1002/ccr3.9186</ArticleId><ArticleId IdType="pii">CCR39186</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et&#xa0;al. Development of a definition of postacute sequelae of SARS&#x2010;CoV&#x2010;2 infection. JAMA. 2023;329(22):1934&#x2010;1946. doi:10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC
. Post&#x2010;COVID conditions: information for health care providers. Accessed July 14, 2023. https://www.cdc.gov/coronavirus/2019&#x2010;ncov/hcp/clinical&#x2010;care/post&#x2010;covid&#x2010;conditions.html
</Citation></Reference><Reference><Citation>
NICE
. COVID&#x2010;19 Rapid Guideline: Managing The Long&#x2010;Term Effects of COVID&#x2010;19. National Institute for Health and Care Excellence; 2024. https://www.nice.org.uk/guidance/NG188
</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHOCCDWGoP&#x2010;Condition . A clinical case definition of post&#x2010;COVID&#x2010;19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2010;e107. doi:10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et&#xa0;al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144. doi:10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et&#xa0;al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC
. COVID or post COVID conditions. CDC; 2023. https://www.cdc.gov/coronavirus/2019&#x2010;ncov/long&#x2010;term&#x2010;effects/index.html
</Citation></Reference><Reference><Citation>Pela G, Goldoni M, Solinas E, et&#xa0;al. Sex&#x2010;related differences in long&#x2010;COVID&#x2010;19 syndrome. J Womens Health (Larchmt). 2022;31(5):620&#x2010;630. doi:10.1089/jwh.2021.0411</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin&#x2010;Frankel J. Clues to long COVID. Science. 2022;376(6599):1261&#x2010;1265. doi:10.1126/science.add4297</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et&#xa0;al. Immunological dysfunction persists for 8 months following initial mild&#x2010;to&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. Nat Immunol. 2022;23(2):210&#x2010;216. doi:10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos&#x2010;Casals M, Brito&#x2010;Zeron P, Mariette X. Systemic and organ&#x2010;specific immune&#x2010;related manifestations of COVID&#x2010;19. Nat Rev Rheumatol. 2021;17(6):315&#x2010;332. doi:10.1038/s41584-021-00608-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia&#x2010;Ramos AE, Martin&#x2010;Nares E, Hernandez&#x2010;Molina G. New onset of autoimmune diseases following COVID&#x2010;19 diagnosis. Cells. 2021;10(12):3592. doi:10.3390/cells10123592</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123592</ArticleId><ArticleId IdType="pmc">PMC8700122</ArticleId><ArticleId IdType="pubmed">34944099</ArticleId></ArticleIdList></Reference><Reference><Citation>Behbahani S, Baltz JO, Droms R, et&#xa0;al. Sarcoid&#x2010;like reaction in a patient recovering from coronavirus disease 19 pneumonia. JAAD Case Rep. 2020;6(9):915&#x2010;917. doi:10.1016/j.jdcr.2020.07.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdcr.2020.07.026</ArticleId><ArticleId IdType="pmc">PMC7378473</ArticleId><ArticleId IdType="pubmed">32837988</ArticleId></ArticleIdList></Reference><Reference><Citation>Polat Ekinci A, Buyukbabani N, Mese S, et&#xa0;al. COVID&#x2010;19&#x2010;triggered sarcoidal granulomas mimicking scar sarcoidosis. J Eur Acad Dermatol Venereol. 2021;35(8):e477&#x2010;e480. doi:10.1111/jdv.17286</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.17286</ArticleId><ArticleId IdType="pmc">PMC8250646</ArticleId><ArticleId IdType="pubmed">33871106</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioffi JRA, Chen W, Smith JP. Hepatic sarcoidosis diagnosis after COVID&#x2010;19 infection. Am J Gastroenterol. 2021;116:S1186.</Citation></Reference><Reference><Citation>Mertz P, Jeannel J, Guffroy A, et&#xa0;al. Granulomatous manifestations associated with COVID19 infection: is there a link between these two diseases? Autoimmun Rev. 2021;20(6):102824. doi:10.1016/j.autrev.2021.102824</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102824</ArticleId><ArticleId IdType="pmc">PMC8056977</ArticleId><ArticleId IdType="pubmed">33864942</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez&#x2010;Alfonso B, Ruiz Solis S, Silva&#x2010;Hernandez L, Pintos Pascual I, Aguado Ibanez S, Salas AC. (18)F&#x2010;FDG&#x2010;PET/CT in SARS&#x2010;CoV&#x2010;2 infection and its sequelae. Rev Esp Med Nucl Imagen Mol (Engl ed). 2021;40(5):299&#x2010;309. doi:10.1016/j.remnie.2021.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.remnie.2021.07.005</ArticleId><ArticleId IdType="pmc">PMC8316133</ArticleId><ArticleId IdType="pubmed">34340958</ArticleId></ArticleIdList></Reference><Reference><Citation>Capaccione KM, McGroder C, Garcia CK, Fedyna S, Saqi A, Salvatore MM. COVID&#x2010;19&#x2010;induced pulmonary sarcoid: a case report and review of the literature. Clin Imaging. 2022;83:152&#x2010;158. doi:10.1016/j.clinimag.2021.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2021.12.021</ArticleId><ArticleId IdType="pmc">PMC8755635</ArticleId><ArticleId IdType="pubmed">35051738</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabufetti A, Borradori L, Heidemeyer K, et&#xa0;al. New onset of sarcoidosis after COVID&#x2010;19 infection. J Eur Acad Dermatol Venereol. 2022;36(10):e756&#x2010;e759. doi:10.1111/jdv.18313</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.18313</ArticleId><ArticleId IdType="pmc">PMC9347996</ArticleId><ArticleId IdType="pubmed">35686935</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kucukardali Y, Gunturk A, Ozturk MA, et&#xa0;al. Is there a Relationship between COVID&#x2010;19 and Sarcoidosis? A Case Report. Archives of Pulmonary and Respiratory Care; 2022. https://pdfs.semanticscholar.org/2b28/4bd0db187a4a393c5fe29de514e3cf3fbb5b.pdf
</Citation></Reference><Reference><Citation>
Robinson R, Nelson A, Hughes SKM. A case report of the Emergernce of Neurosarcoidosis after COVID&#x2010;19 infection. J Neurol Neurosurg Psychaitry. 2022;93(6):A140&#x2010;A140. https://jnnp.bmj.com/content/93/6/A140.2
</Citation></Reference><Reference><Citation>A MDDLSMMT . Neurosarcoidosis after infection with COVID&#x2010;19, a case report and review of the literature (P6&#x2010;1.005). Neurology. 2022;98(18 supplement):3828. doi:10.1212/WNL.98.18_supplement.3828</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.98.18_supplement.3828</ArticleId></ArticleIdList></Reference><Reference><Citation>Somboonviboon D, Wattanathum A, Keorochana N, Wongchansom K. Sarcoidosis developing after COVID&#x2010;19: a case report. Respirol Case Rep. 2022;10(9):e01016. doi:10.1002/rcr2.1016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcr2.1016</ArticleId><ArticleId IdType="pmc">PMC9366406</ArticleId><ArticleId IdType="pubmed">35978720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokhriyal SC, Nabeel Pasha M, Khan A, Uwiringiyimana R, Idris H. Sarcoidosis presenting as a lung mass in a patient with COVID&#x2010;19 infection: a case report. Cureus. 2023;15(5):e39136. doi:10.7759/cureus.39136</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.39136</ArticleId><ArticleId IdType="pmc">PMC10275395</ArticleId><ArticleId IdType="pubmed">37332432</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003;289(24):3300&#x2010;3303. doi:10.1001/jama.289.24.3300</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.24.3300</ArticleId><ArticleId IdType="pubmed">12824213</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteves T, Aparicio G, Garcia&#x2010;Patos V. Is there any association between sarcoidosis and infectious agents?: a systematic review and meta&#x2010;analysis. BMC Pulm Med. 2016;16(1):165. doi:10.1186/s12890-016-0332-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-016-0332-z</ArticleId><ArticleId IdType="pmc">PMC5126827</ArticleId><ArticleId IdType="pubmed">27894280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID&#x2010;19: mechanisms underlying disease severity and progression. Physiology (Bethesda). 2020;35(5):288&#x2010;301. doi:10.1152/physiol.00019.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00019.2020</ArticleId><ArticleId IdType="pmc">PMC7426542</ArticleId><ArticleId IdType="pubmed">32783610</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS&#x2010;CoV&#x2010;2&#x2010;specific immune response and the pathogenesis of COVID&#x2010;19. Int J Mol Sci. 2022;23(3):1716. doi:10.3390/ijms23031716</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Herran M, Beltran S, Rojas M. Is post&#x2010;COVID syndrome an autoimmune disease? Expert Rev Clin Immunol. 2022;18(7):653&#x2010;666. doi:10.1080/1744666X.2022.2085561</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2022.2085561</ArticleId><ArticleId IdType="pubmed">35658801</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2010;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares&#x2010;Zapatero D, Chalon P, Kohn L, et&#xa0;al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2010;1487. doi:10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine&#x2010;based pathophysiology of long COVID symptoms. Front Med (Lausanne). 2023;10:1011936. doi:10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Votto M, Castagnoli R, Marseglia GL, Licari A, Brambilla I. COVID&#x2010;19 and autoimmune diseases: is there a connection? Curr Opin Allergy Clin Immunol. 2023;23(2):185&#x2010;192. doi:10.1097/ACI.0000000000000888</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACI.0000000000000888</ArticleId><ArticleId IdType="pubmed">36728317</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;23(10):618&#x2010;634. doi:10.1038/s41577-023-00904-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed U, Subramanian A, Wraith DC, et&#xa0;al. Incidence of immune&#x2010;mediated inflammatory diseases following COVID&#x2010;19: a matched cohort study in UK primary care. BMC Med. 2023;21(1):363. doi:10.1186/s12916-023-03049-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03049-5</ArticleId><ArticleId IdType="pmc">PMC10512476</ArticleId><ArticleId IdType="pubmed">37735654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Yen&#x2010;Ting Chen T, Wang SI, Hung YM, Chen HY, Wei CJ. Risk of autoimmune diseases in patients with COVID&#x2010;19: a retrospective cohort study. EClinicalMedicine. 2023;56:101783. doi:10.1016/j.eclinm.2022.101783</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F, Ehm F, Vivirito A, et&#xa0;al. Incident autoimmune diseases in association with SARS&#x2010;CoV&#x2010;2 infection: a matched cohort study. Clin Rheumatol. 2023;42(10):2905&#x2010;2914. doi:10.1007/s10067-023-06670-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-023-06670-0</ArticleId><ArticleId IdType="pmc">PMC10497688</ArticleId><ArticleId IdType="pubmed">37335408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher EK, Cosovic A, Dzidic&#x2010;Krivic A, Farhat EK, Pinjic E, Sher F. Covid&#x2010;19 a triggering factor of autoimmune and multi&#x2010;inflammatory diseases. Life Sci. 2023;319:121531. doi:10.1016/j.lfs.2023.121531</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2023.121531</ArticleId><ArticleId IdType="pmc">PMC9969758</ArticleId><ArticleId IdType="pubmed">36858313</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev. 2013;255(1):197&#x2010;209. doi:10.1111/imr.12091</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12091</ArticleId><ArticleId IdType="pmc">PMC3971377</ArticleId><ArticleId IdType="pubmed">23947356</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762. doi:10.3390/v11080762</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein HM, Rahal EA. The role of viral infections in the development of autoimmune diseases. Crit Rev Microbiol. 2019;45(4):394&#x2010;412. doi:10.1080/1040841X.2019.1614904</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841X.2019.1614904</ArticleId><ArticleId IdType="pubmed">31145640</ArticleId></ArticleIdList></Reference><Reference><Citation>
King A. How pandemics strengthen links between viruses and autoimmunity. Nature. 2021;595:S48&#x2010;S50. https://www.nature.com/articles/d41586&#x2010;021&#x2010;01835&#x2010;w
</Citation></Reference><Reference><Citation>Zhao M, Tian C, Cong S, Di X, Wang K. From COVID&#x2010;19 to sarcoidosis: how similar are these two diseases? Front Immunol. 2022;13:877303. doi:10.3389/fimmu.2022.877303</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.877303</ArticleId><ArticleId IdType="pmc">PMC9124764</ArticleId><ArticleId IdType="pubmed">35615369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C, Bayry J. High risk of autoimmune diseases after COVID&#x2010;19. Nat Rev Rheumatol. 2023;19(7):399&#x2010;400. doi:10.1038/s41584-023-00964-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-023-00964-y</ArticleId><ArticleId IdType="pmc">PMC10096101</ArticleId><ArticleId IdType="pubmed">37046064</ArticleId></ArticleIdList></Reference><Reference><Citation>Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385(11):1018&#x2010;1032. doi:10.1056/NEJMra2101555</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2101555</ArticleId><ArticleId IdType="pubmed">34496176</ArticleId></ArticleIdList></Reference><Reference><Citation>Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527&#x2010;534. doi:10.1097/MCP.0000000000000715</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0000000000000715</ArticleId><ArticleId IdType="pmc">PMC7755458</ArticleId><ArticleId IdType="pubmed">32701677</ArticleId></ArticleIdList></Reference><Reference><Citation>Belperio JA, Shaikh F, Abtin FG, et&#xa0;al. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA. 2022;327(9):856&#x2010;867. doi:10.1001/jama.2022.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.1570</ArticleId><ArticleId IdType="pubmed">35230389</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Cinetto F, Mantini C, et&#xa0;al. Sarcoidosis and COVID&#x2010;19: At the cross&#x2010;road between immunopathology and clinical manifestation. Biomedicine. 2022;10(10):1271198. doi:10.3390/biomedicines10102525</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102525</ArticleId><ArticleId IdType="pmc">PMC9599235</ArticleId><ArticleId IdType="pubmed">36289785</ArticleId></ArticleIdList></Reference><Reference><Citation>Brjalin V, Salupere R, Tefanova V, Prikk K, Lapidus N, Joeste E. Sarcoidosis and chronic hepatitis C: a case report. World J Gastroenterol. 2012;18(40):5816&#x2010;5820. doi:10.3748/wjg.v18.i40.5816</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v18.i40.5816</ArticleId><ArticleId IdType="pmc">PMC3484354</ArticleId><ArticleId IdType="pubmed">23155326</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownell I, Ramirez&#x2010;Valle F, Sanchez M, Prystowsky S. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol. 2011;45(5):899&#x2010;905. doi:10.1165/rcmb.2010-0433TR</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2010-0433TR</ArticleId><ArticleId IdType="pmc">PMC3361363</ArticleId><ArticleId IdType="pubmed">21659662</ArticleId></ArticleIdList></Reference><Reference><Citation>Prnjavorac B, Mujakovic A, Prnjavorac L, et&#xa0;al. Chest x&#x2010;ray resolution after SARS&#x2010;CoV&#x2010;2 infection. Med Glas (Zenica). 2021;18(2):370&#x2010;377. doi:10.17392/1391-21</Citation><ArticleIdList><ArticleId IdType="doi">10.17392/1391-21</ArticleId><ArticleId IdType="pubmed">34331436</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>